ETHIQA XR Trademark

Trademark Overview

On Thursday, November 30, 2017, a trademark application was filed for ETHIQA XR with the United States Patent and Trademark Office. The USPTO has given the ETHIQA XR trademark a serial number of 87703098. The federal status of this trademark filing is REGISTERED as of Tuesday, September 22, 2020. This trademark is owned by FIDELIS PHARMACEUTICALS LLC. The ETHIQA XR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, buprenorphine extended release injectable suspension to provide analgesia for laboratory animals
ethiqa xr

General Information

Serial Number87703098
Word MarkETHIQA XR
Filing DateThursday, November 30, 2017
Status700 - REGISTERED
Status DateTuesday, September 22, 2020
Registration Number6158526
Registration DateTuesday, September 22, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 18, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, buprenorphine extended release injectable suspension to provide analgesia for laboratory animals
NOT AVAILABLE"XR"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 11, 2017
Primary Code005
First Use Anywhere DateThursday, August 6, 2020
First Use In Commerce DateThursday, August 6, 2020

Trademark Owner History

Party NameFIDELIS ANIMAL HEALTH, INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressNORTH BRUNSWICK, NJ 08902
Party NameFIDELIS PHARMACEUTICALS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressNORTH BRUNSWICK, NJ 08902
Party NameFIDELIS PHARMACEUTICALS LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNorth Brunswick, NJ 08902
Party NameFIDELIS PHARMACEUTICALS LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNorth Brunswick, NJ 08902
Party NameFIDELIS PHARMACEUTICALS LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew Rochelle, NY 10801

Trademark Events

Event DateEvent Description
Monday, December 4, 2017NEW APPLICATION ENTERED
Monday, December 11, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 13, 2018ASSIGNED TO EXAMINER
Wednesday, March 14, 2018NON-FINAL ACTION WRITTEN
Wednesday, March 14, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 14, 2018NON-FINAL ACTION E-MAILED
Friday, April 13, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 13, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 13, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 7, 2018NON-FINAL ACTION WRITTEN
Monday, May 7, 2018NON-FINAL ACTION E-MAILED
Monday, May 7, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, August 4, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 4, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, August 4, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, August 4, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 16, 2018ASSIGNED TO LIE
Wednesday, August 29, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 18, 2018PUBLISHED FOR OPPOSITION
Tuesday, September 18, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 13, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 28, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 28, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 28, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 28, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 13, 2019SOU EXTENSION 1 FILED
Tuesday, May 14, 2019TEAS PETITION TO REVIVE RECEIVED
Tuesday, May 14, 2019PETITION TO REVIVE-GRANTED
Tuesday, May 14, 2019SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, May 14, 2019NOTICE OF REVIVAL - E-MAILED
Monday, June 17, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 17, 2019SOU EXTENSION 1 GRANTED
Tuesday, June 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 31, 2019SOU TEAS EXTENSION RECEIVED
Thursday, October 31, 2019SOU EXTENSION 2 FILED
Thursday, October 31, 2019SOU EXTENSION 2 GRANTED
Saturday, November 2, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 2, 2020SOU TEAS EXTENSION RECEIVED
Thursday, April 2, 2020SOU EXTENSION 3 FILED
Thursday, April 2, 2020SOU EXTENSION 3 GRANTED
Saturday, April 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 7, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 7, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 7, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 17, 2020TEAS STATEMENT OF USE RECEIVED
Monday, August 17, 2020USE AMENDMENT FILED
Wednesday, August 19, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 20, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, August 21, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 22, 2020REGISTERED-PRINCIPAL REGISTER
Thursday, May 19, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, June 22, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, September 22, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

ethiqa provide suspension analgesia laboratory animals injectable release preparations namely buprenorphine